No Data
10-Q/A: Quarterly report (Amendment)
10-Q: Q3 2024 Earnings Report
CERo Therapeutics Holdings Receives FDA Clearance For Phase 1 Trials Of Lead Compound CER-1236 In Acute Myelogenous Leukemia (AML)
12 Health Care Stocks Moving In Friday's Pre-Market Session
CERo Therapeutics CERO IND Cleared; TFF Pharmaceutical TFFP Winding Down
Trending Stocks Today | The Arena Group Surges 182.45%
November 15th - US stocks trending in regular trading hours.Gainers: $The Arena Group(AREN.US)$ surges 182.45% to $1.61 with a turnover of $151.46 million. $CERo Therapeutics(CERO.US)$ soars 58.17%
No Data
No Data